Cargando…
Role of synthetic retinoic acid derivatives in Chronic Lymphocytic Leukemia and Multiple Myeloma
Autores principales: | Saeed, Ayman T, Murphy, P, Napoletano, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582896/ http://dx.doi.org/10.1186/1753-6561-7-S1-O3 |
Ejemplares similares
-
The Coexistence of Chronic Lymphocytic Leukemia and Multiple Myeloma
por: Hangül, Ceren, et al.
Publicado: (2019) -
A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression
por: Farinello, Diego, et al.
Publicado: (2018) -
OAB-045: COVID-19 vaccine responsiveness in patients with Multiple Myeloma and Waldenström Macroglobulinemia
por: Branagan, Andrew, et al.
Publicado: (2021) -
OAB-049: Poor post-vaccination anti-SARS-CoV-2-antibody response in patients with Multiple Myeloma correlates with low CD19+ B-lymphocyte count and anti-CD38 treatment
por: Ghandili, Susanne, et al.
Publicado: (2021) -
OAB-046: COVID-19 infection in multiple myeloma patients – retrospective analysis of 371 Czech patients
por: Radocha, Jakub, et al.
Publicado: (2021)